01.14.26 -- Europe In 2026: Resilience Through Uncertainty

Explore how spray-drying technologies can enhance the stability and efficacy of biologics, improving formulations and producing powders for nasal and pulmonary dosage forms. Click to read the whitepaper.

Explore innovative solutions for improving the solubility and bioavailability of poorly soluble compounds in solid oral dosage forms to enhance drug delivery and therapeutic effectiveness.

Discover how PBPK models combined with in vitro tools and solubility enhancement expertise can be used to identify and mitigate absorption risks in early drug development.

Observe how compound libraries leverage chemical diversity and advanced filtering to accelerate hit-to-lead development and enhance early-stage drug discovery.

Combining relational risk analysis (ReRA) modeling strategies with hazard analysis and critical control point (HACCP) and other process flow risk analysis methods makes them more efficient.

Leachables risk is a key concern in biomanufacturing. Review best practices for evaluating risks from polymeric single-use systems to support robust assessments and compliance.

Formulation and pharmacy experts share their secrets for completing clinical trials and resolving issues that could impact your drug development program’s timeline.

See a reliable solution for labeling small batches of medical products, including vials, syringes, and cartridges, that fully automatic machines struggle to handle.

Overcoming development complexity requires robust process safety. Solutions can safely scale challenging reactions, like click chemistry and cryogenic organometallics, improving results.

Flawless tablet production starts with precision CT scanning. Uncover hidden defects, ensure product integrity, and deliver quality every time.

Review our expertise across a wide range of global markets. Our experience in securing regulatory approvals and navigating market challenges positions us as a trusted partner.

A global network of manufacturing sites supports discovery through commercialization, offering cost-efficient outsourcing and regulatory starting material capabilities for streamlined drug development.